Use of composite scores in the quantification of deterioration in multiple sclerosis
- 1 August 1999
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 5 (4) , 220-222
- https://doi.org/10.1177/135245859900500405
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceAnnals of Neurology, 1997
- Clinical outcomes assessment in multiple sclerosisAnnals of Neurology, 1996
- Clinical Outcome Measures for Multiple SclerosisPublished by Springer Nature ,1996
- Statistical and Design Considerations for Multiple Sclerosis Clinical TrialsPublished by Springer Nature ,1996
- Clinical scales for multiple sclerosisJournal of the Neurological Sciences, 1996
- Outcomes assessment in multiple sclerosis clinical trials: a critical analysisMultiple Sclerosis Journal, 1995
- Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisAnnals of Neurology, 1995
- Rating neurologic impairment in multiple sclerosisNeurology, 1983